Similar Items: Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
- Simulation of long‐term lecanemab treatment effect on Alzheimer's disease progression
- Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging
- Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
- A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
- The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias
- Longitudinal changes in DTI‐ALPS and choroid plexus volume relative to CSF biomarkers during lecanemab treatment in mild cognitive impairment: A pilot study